IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis

Advances in Medical Sciences

Volumn 55, Issue 2, 2010, Pages 254-260

  Glowacka, E ^a   Lewkowicz, P ^a   Rotsztejn, H ^b   Zalewska, A ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

cytokines secretion; fibroblasts; neutrophils; psoriasis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; INFLAMMATION; KERATINOCYTE; MALE; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENESIS; PSORIASIS; SUPERNATANT;

EID: 78650503859     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-010-0037-0     Document Type: Article

References (37)

1. Cimmino MA. Epidemiology of psoriasis and psoriatic arthritis. Reumatismo. 2007 Mar; 59 (Suppl 1):19-24.
2. Büchau AS, Gallo RL. Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol. 2007 Nov-Dec;25(6):616-24.
3. Bos JD. Psoriasis, innate immunity, and gene pools. J Am Acad Dermatol. 2007 Mar; 56(3):468-71.
4. Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S67-80.
5. De Rosa G, Mignogna C. The histopathology of psoriasis. Reumatismo. 2007 Mar; 59 (Suppl 1):46-8.
6. Loffredo S, Ayala F, Marone GC, Genovese A, Marone G. Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives. Reumatismo. 2007 Mar; 59 (Suppl 1):28-39.
7. Boyman O, Curdin C, Tonel G, Gilliet M , Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 2007 Feb;28(2):51-7.
8. Fredriksson T, Pettersson U. Severe psoriasisoral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44.
9. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194-9.
10. Zalewska A, Glowacka E, Wyczólkowska J, Tchórzewski H, Narbutt J, Sysa-Jedrzejowska A. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators Inflamm. 2006;2006(1):81767.
11. Nickoloff BJ, Xin H, Nestle FO, Qin JZ. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007 Nov-Dec;25(6):568-73.
12. Victor FC, Gottlieb AB. TNF-alpha and apoptosis: Implications for the pathogenesis and treatment of psoriasis. J Drugs Dermatol. 2002 Dec;1(3):264-75.
13. Abanmi A, Al Harthi F, Al Agla R, Khan HA, Tariq M. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int. J Dermatol. 2005 Jan;44(1):82-3.
14. Prens EP, Benne K, van Damme J, Bakkus M, Brakel K, Benner R, van Joost T. Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol.1990 Dec;95(6 Suppl):121S- 124S.
15. Schröder JM. Peptides and cytokines. Arch Dermatol Res. 1992;284 Suppl 1:S22-26.
16. Mizutani H, Ohmoto Y, Mizutani T, Murata M, Shimizu M. Role of increased production of monocytes TNFalpha, IL-1beta and IL-6 in psoriasis: Relation to focal infection, disease activity and responses to treatments. J Dermatol Sci. 1997 Feb;14(2):145-53.
17. Gordon KB, Ruderman EM. The treatment of psoriasis and psoriatic arthritis: An interdisciplinary approach. J Am Acad Dermatol. 2006 Mar; 54(3 Suppl 2):S85-91.
18. Buckley CD, Filer A, Haworth O, Parsonage G, Salmon M. Defining a role for fibroblasts in persistence of chronic inflammatory joint disease. Ann Rheum Dis. 2004 Nov;63 Suppl 2:II92-II95.
19. Jordana M, Särnstrand B, Sime PJ, Ramis I. Immuneinflammatory functions of fibroblasts. Eur Respir J. 1994 Dec;7(12):2212-22.
20. Debets R, Hegmans JP, Buurman WA, Benner R, Prens EP. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression. Cytokine. 1996 Jan;8(1):80-8. (Pubitemid 26110941)
21. Miura H, Sanso S, Higashiyama M, Yoshikawa K, Itami S. Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: Dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res. 2000 Dec;292(12):590-7.
22. Ishikawa H, Mitsuhashi Y, Takagi Y, Hashimoto I. Psoriatic fibroblasts enhance cornified envelope formation in normal keratinocytes in vitro. Arch Dermatol Res. 1997 Aug;289(9):551-3.
23. Cunliffe IA, Richardson PS, Rees RC, Rennie IG. Effect of TNF, IL-1, and IL-6 on proliferation of human Tenon's capsule fibroblasts in tissue culture. Br J Ophthalmol. 1995 Jun;79(6):590-5.
24. Konstantinova NV, Duong DM, Remenyik E, Hazarika P, Chuang A, Duvic M. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblast. J Invest Dermatol.1996 Oct:107(4):615-21.
25. Cicco NA, Lindemann J, Content P, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte-macrophage colonystimulating factor and tumor necrosis factor-alpha. Blood. 1990 May 15;75(10):2049-52.
26. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci USA. 1990 Sep;87(17):6758-61.
27. Gosselin E, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, INF-gamma, and IL-3. J Immunol. 1993 Aug 1;151(3):1482-90.
28. Matsukawa A, Yoshinaga M. Neutrophils as a source of cytokine in inflammation. Histol Histopathol. 1999 Apr;14(2):511-6.
29. Duan H, Koga T, Kohda F, Hara H, Urabe K, Furue M. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci. 2001 Jun;26(2):119-24.
30. Gillitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8mRNA in situ. J Invest Dermatol. 1991 Jul;97(1):73-9.
31. Debets R, Hegmans JP, Deleuran M, Hooft S, Bennner R, Prens EP. Expression of cytokine and their receptors by psoriatic fibroblasts. I. Altered IL-6 synthesis. Cytokine. 1996 Jan;8(1):71-9.
32. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J Pathol. 1997 Aug;151(2):317-22.
33. Rosmarin D, Strober BE. The potential of interleukin 12 inhibition in the treatment of psoriasis. J Drugs Dermatol. 2005 May-Jun;4(3):318-25.
34. Asadullah K, Döcke WD, Volk HD, Sterry W. The pathophysiological role of cytokines in psoriasis. Drugs Today (Barc). 1999 Dec;35(12):913-24.
35. Rotsztejn H, Zalewska A, Trznadel-Budzko E, Lewkowicz P, Banasik M, Tchórzewski H. Influence of systemic photochemotherapy on regulatory T cells and selected cytokine productions in psoriatic patients: A pilot study. Med Sci Monit. 2005 Dec; 11(12):CR 594-8.
36. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, Döcke WD. IL-10 is a key cytokine in psoriasis. J Clin Invest. 1998 Feb 15;101(4):783-94.
37. Terui T, Ozawa M, Tagami H. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: A neutrophil-asssociated inflammationboosting loop. Exp Dermatol. 2000 Feb;9(1):1-10.